
Dexcom receives FDA clearance for G7 15 Day glucose monitoring system
Glucose monitoring specialist Dexcom announced it received FDA clearance for its G7 15 Day continuous glucose monitoring (CGM) system for people 18 and older with type 1, type 2 and gestational diabetes. G7 15 Day, scheduled to launch in the second half …